Nucryst Pharmaceuticals

Fort Saskatchewan, AB
Area: 2,350 m
Project Cost: Confidential
Responsibilities:

Basis Design

Gap Analysis

FDA Compliant
Design Control
Program

Protocol Execution

Nucryst Pharmaceuticals develops,

manufactures, and commercializes medical
products that fight infection and inflammation.
Nucryst transferred their operations from New
Jersey to combine with their facility in Fort
Saskatchewan.
PharmEng developed a Gap Analysis and
Design Basis for this facility in order to:
Improve Work Flow
Have Minimal Construction
Minimize Costs
PharmEng provided Nucryst Pharmaceuticals
with additional services including;
Manufacturing Design Control Program
Regulatory Affairs